Kazuhiro Kondo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Donepezil ameliorates fatigue and depression in PASC patients with HHV-6B SITH-1-induced acetylcholine deficiency.
Journal: Frontiers in pharmacology
Published: February 09, 2026
Human placental extract, melsmon, suppresses stress-induced neuroinflammation and peripheral inflammation in a mouse model of depression.
Journal: Frontiers in pharmacology
Published: January 13, 2026
Association Between Plasma SITH-1 Antibody Titers and Treatment Trajectory of Treatment-Resistant Depression.
Journal: Neuropsychopharmacology reports
Published: August 01, 2025
Association of anti SITH 1 antibody titer with mental stress and intracranial aneurysms.
Journal: Scientific reports
Published: July 21, 2025
Efficacy of Donepezil for Fatigue and Psychological Symptoms in Post-COVID-19 Condition: Study Protocol for a Multicenter Randomized, Placebo-controlled, Double-blind Trial.
Journal: Annals of clinical epidemiology
Published: February 01, 2024
Identification of a strong genetic risk factor for major depressive disorder in the human virome.
Journal: iScience
Published: June 13, 2023
Alterations of neuropsychiatric symptoms in dementia patients during hospitalization in a dementia ward.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
Published: May 03, 2023
SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production.
Journal: iScience
Published: October 20, 2022
VP26, a herpes simplex virus type 1 capsid protein, increases DNA methylation in COASY promoter region.
Journal: Brain, behavior, & immunity - health
Published: June 30, 2022
Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients.
Journal: Journal of personalized medicine
Published: June 07, 2022
Last Updated: 09/26/2026